BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29523273)

  • 1. Maternal serum levels and placental expression of hepcidin in preeclampsia.
    Cardaropoli S; Todros T; Nuzzo AM; Rolfo A
    Pregnancy Hypertens; 2018 Jan; 11():47-53. PubMed ID: 29523273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia.
    Mittal P; Espinoza J; Hassan S; Kusanovic JP; Edwin SS; Nien JK; Gotsch F; Than NG; Erez O; Mazaki-Tovi S; Romero R
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):651-9. PubMed ID: 17701665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex expression changes of the placental endothelin system in early and late onset preeclampsia, fetal growth restriction and gestational diabetes.
    Dieber-Rotheneder M; Beganovic S; Desoye G; Lang U; Cervar-Zivkovic M
    Life Sci; 2012 Oct; 91(13-14):710-5. PubMed ID: 22580289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
    Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of maternal obesity on iron status, placental transferrin receptor expression and hepcidin expression in human pregnancy.
    Garcia-Valdes L; Campoy C; Hayes H; Florido J; Rusanova I; Miranda MT; McArdle HJ
    Int J Obes (Lond); 2015 Apr; 39(4):571-8. PubMed ID: 25614087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid profiling in maternal and fetal circulations in preeclampsia and fetal growth restriction-a prospective case control observational study.
    Alahakoon TI; Medbury HJ; Williams H; Lee VW
    BMC Pregnancy Childbirth; 2020 Jan; 20(1):61. PubMed ID: 32000699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating RNA coding genes regulating apoptosis in maternal blood in severe early onset fetal growth restriction and pre-eclampsia.
    Whitehead CL; Walker SP; Lappas M; Tong S
    J Perinatol; 2013 Aug; 33(8):600-4. PubMed ID: 23429544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of placental neuropilin-1 in fetal growth restriction.
    Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
    Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia.
    Palmer KR; Kaitu'u-Lino TJ; Cannon P; Tuohey L; De Silva MS; Varas-Godoy M; Acuña S; Galaz J; Tong S; Illanes SE
    J Matern Fetal Neonatal Med; 2017 Mar; 30(6):635-639. PubMed ID: 27124553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications.
    Kim MJ; Kim SY; Park SY; Ahn HK; Chung JH; Ryu HM
    Placenta; 2013 Jan; 34(1):57-61. PubMed ID: 23187089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent systemic 11ß-dehydroxysteroid dehydrogenase 2 activity is increased in preeclampsia but not in intrauterine growth restriction.
    Vasku M; Kleine-Eggebrecht N; Rath W; Mohaupt MG; Escher G; Pecks U
    Pregnancy Hypertens; 2018 Jan; 11():7-11. PubMed ID: 29523277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester adiponectin and subsequent development of preeclampsia or fetal growth restriction.
    Valdés ER; Lattes KA; Muñoz HS; Barja PY; Papapietro KV
    Gynecol Obstet Invest; 2011; 72(3):152-6. PubMed ID: 21912074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationships between concentrations of free fatty acid in serum and oxidative-damage levels in placental mitochondria and preeclampsia].
    Yan JY; Xu X
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):412-7. PubMed ID: 22932105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
    Bersinger NA; Ødegård RA
    Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polymorphism in Cyclophilin A gene and its serum and placental expression in Han Chinese women with severe preeclampsia.
    Sun W; Xu Y; Xin Q; Zhang Y; Cui B; Hong F
    Pregnancy Hypertens; 2019 Jan; 15():84-92. PubMed ID: 30825933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential levels of surfactant protein A, surfactant protein D, and progesterone to estradiol ratio in maternal serum before and after the onset of severe early-onset preeclampsia.
    Kale K; Vishwekar P; Balsarkar G; Jassawalla MJ; Sawant G; Madan T
    Am J Reprod Immunol; 2020 Feb; 83(2):e13208. PubMed ID: 31702086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early- and late-onset preeclampsia and the DNA methylation of circadian clock and clock-controlled genes in placental and newborn tissues.
    van den Berg CB; Chaves I; Herzog EM; Willemsen SP; van der Horst GTJ; Steegers-Theunissen RPM
    Chronobiol Int; 2017; 34(7):921-932. PubMed ID: 28613964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the correlation between placental and serum placenta growth factor in preeclampsia.
    Weed S; Bastek JA; Anton L; Elovitz MA; Parry S; Srinivas SK
    Am J Obstet Gynecol; 2012 Aug; 207(2):140.e1-6. PubMed ID: 22704767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation.
    Rafaeli-Yehudai T; Imterat M; Douvdevani A; Tirosh D; Benshalom-Tirosh N; Mastrolia SA; Beer-Weisel R; Klaitman V; Riff R; Greenbaum S; Alioshin A; Rodavsky Hanegbi G; Loverro G; Catalano MR; Erez O
    PLoS One; 2018; 13(7):e0200360. PubMed ID: 30001403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.